Health

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

TribeNews
By TribeNews Add a Comment
0 Min Read
Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

MedPage Today) — Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded FDA approval.
Vutrisiran, a transthyretin-directed…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app